Sugi Predict

Sugi Predict / Compounds / SCHEMBL4827664

SCHEMBL4827664

SCHEMBL4827664

Cc1ccc(C)c(B2OC(C)(C)C(C)(C)O2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LPL P06858 11/20 0.36
▸ LIPG Q9Y5X9 11/20 0.36
▸ TDP1 Q9NUW8 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ P2RX7 Q99572 1/20 0.32
▸ TP53 P04637 2/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2A6 P11509 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29688166 1.00 LPL (0.36) LPLLIPGTDP1ALDH1A1MAPK1
SCHEMBL7162437 0.84 LPL (0.38) LPLLIPGTDP1ALDH1A1KDM4E
SCHEMBL29424563 0.84 LPL (0.38) LPLLIPGTDP1ALDH1A1KDM4E
SCHEMBL3191098 0.82 TDP1 (0.45) LPLLIPGTDP1ALDH1A1MAPK1
SCHEMBL15553966 0.81 LPL (0.32) LPLLIPGALDH1A1HIF1A
SCHEMBL18039553 0.81 ACHE (0.37) LPLLIPGALDH1A1MAPK1KDM4E
SCHEMBL1753525 0.81 TRPA1 (0.43) LPLLIPGTDP1ALDH1A1KDM4E
SCHEMBL22715907 0.81 LPL (0.34) LPLLIPGMAPK1P2RX7
Hydrochloric Acid SCHEMBL16753825 0.81 TDP1 (0.43) LPLLIPGTDP1ALDH1A1MAPK1
SCHEMBL17443668 0.81 LPL (0.41) LPLLIPGALDH1A1P2RX7HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12479873-B2 Metal complexes UDC Ireland (IE) 2025-11-25 — — US disclosed
US-20230322826-A1 METAL COMPLEXES UDC IRELAND LIMITED (IE) 2023-10-12 — — US disclosed
US-11713332-B2 Metal complexes MERCK PATENT GMBH (DE) 2023-08-01 — — US disclosed
US-20230151001-A9 IMIDAZOPYRIDINE DERIVATIVES AND AZA-IMIDAZOPYRIDINE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-05-18 — — US disclosed
CN-109415344-B Metal complexes 默克专利有限公司 2022-06-03 — — CN disclosed
EP-3484868-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2020-11-25 — — EP disclosed
US-20190315787-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-10-17 — — US disclosed
EP-3134396-B1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2019-09-18 — — EP disclosed
EP-3484868-A1 METAL COMPLEXES Merck Patent GmbH (DE) 2019-05-22 — — EP disclosed
CN-109415344-A Metal complex 默克专利有限公司 2019-03-01 — — CN disclosed
US-7271406-B2 Electron transport agents for organic electronic devices 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-09-18 — — US disclosed
US-7271406-B2 Electron transport agents for organic electronic devices 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-09-18 — — US disclosed
US-7094902-B2 Electroactive polymers 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-08-22 — — US disclosed
US-20060155106-A1 ELECTROACTIVE POLYMERS 3M INNOVATIVE PROPERTIES COMPANY 2006-07-13 — — US disclosed
EP-1618169-A1 ELECTRON TRANSPORT AGENTS FOR ORGANIC ELECTRONIC DEVICES 3M Innovative Properties Company (US) 2006-01-25 — — EP disclosed
EP-1573789-A2 ELECTROACTIVE POLYMERS 3M Innovative Properties Company (US) 2005-09-14 — — EP disclosed
WO-2004102615-A2 ELECTROACTIVE POLYMERS 3M INNOVATIVE PROPERTIES COMPANY (US) 2004-11-25 — — WO disclosed
WO-2004096948-A1 ELECTRON TRANSPORT AGENTS FOR ORGANIC ELECTRONIC DEVICES 3M INNOVATIVE PROPERTIES COMPANY (US) 2004-11-11 — — WO disclosed
US-20040214036-A1 Electron transport agents for organic electronic devices 3M INNOVATIVE PROPERTIES COMPANY 2004-10-28 — — US disclosed
US-20040062930-A1 Electroactive polymers 3M INNOVATIVE PROPERTIES COMPANY 2004-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12479873-B2 Metal complexes AP1M1, SOD1, AP3M1 LPL 3378/4885LIPG 3352/4885TDP1 3442/4885
US-20230151001-A9 IMIDAZOPYRIDINE DERIVATIVES AND AZA-IMIDAZOPYRIDINE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND USES THEREOF JAK1, JAK2, JAK3 LPL 3733/4885LIPG 2670/4885TDP1 1034/4885
US-20190315787-A1 METAL COMPLEXES AP1M1, SOD1, AP3M1 LPL 3378/4885LIPG 3352/4885TDP1 3442/4885
US-11713332-B2 Metal complexes AP1M1, SOD1, AP3M1 LPL 3378/4885LIPG 3352/4885TDP1 3442/4885
US-20230322826-A1 METAL COMPLEXES AP1M1, SOD1, AP3M1 LPL 3378/4885LIPG 3352/4885TDP1 3442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.